지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2024.5
- 수록면
- 195 - 209 (15page)
- DOI
- 10.3343/alm.2023.0389
이용수
초록· 키워드
오류제보하기
Circulating tumor DNA (ctDNA) has emerged as a promising tool for various clinical applications, including early diagnosis, therapeutic target identification, treatment response monitoring, prognosis evaluation, and minimal residual disease detection. Consequently, ctDNA assays have been incorporated into clinical practice. In this review, we offer an in-depth exploration of the clinical implementation of ctDNA assays. Notably, we examined existing evidence related to pre-analytical procedures, analytical components in current technologies, and result interpretation and reporting processes. The primary objective of this guidelines is to provide recommendations for the clinical utilization of ctDNA assays.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
혈중 순환 종양 DNA 분석 임상 적용 가이드라인 소개
Laboratory Medicine Online
2024 .07
-
Clinical Circulating Tumor DNA Testing for Precision Oncology
Cancer Research and Treatment
2023 .04
-
Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers
Cancer Research and Treatment
2023 .04
-
Feasibility of Circulating Tumor DNA Analysis in Patients with Follicular Lymphoma
Cancer Research and Treatment
2024 .07
-
Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Clinical and Molecular Hepatology
2024 .04
-
Implication of Pre- and Post-Radiotherapy ctDNA Dynamics in Patients with Residual Triple-Negative Breast Cancer at Surgery after Neoadjuvant Chemotherapy: Findings from a Prospective Observational Study
Cancer Research and Treatment
2024 .04
-
Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma
Cancer Research and Treatment
2022 .04
-
A Phase II Trial of Osimertinib in the Second-Line Treatment of Non-small Cell Lung Cancer with the EGFR T790M Mutation, Detected from Circulating Tumor DNA: LiquidLung-O-Cohort 2
Cancer Research and Treatment
2019 .01
-
Circulating Tumor DNA Reflects Histologic and Clinical Characteristics of Various Lymphoma Subtypes
Cancer Research and Treatment
2024 .01
-
Targeted Liquid Biopsy Using Irradiation to Facilitate the Release of Cell-Free DNA from a Spatially Aimed Tumor Tissue
Cancer Research and Treatment
2022 .01
-
Evaluation of Circulating Tumor DNA in Patients with Ovarian Cancer Harboring Somatic PIK3CA or KRAS Mutations
Cancer Research and Treatment
2020 .01
-
Circulating Tumor DNA–Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas
Cancer Research and Treatment
2023 .01
-
Optimization of a Protocol for Isolating Cell-free DNA From Cerebrospinal Fluid
Annals of Laboratory Medicine
2024 .05
-
Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in Ovarian Cancer
Cancer Research and Treatment
2020 .01
-
위암에서의 순환종양핵산
Korean Journal of Helicobacter Upper Gastrointestinal Research
2018 .01
-
Clinical Practice Guidelines for Pre-Analytical Procedures of Plasma Epidermal Growth Factor Receptor Variant Testing
Annals of Laboratory Medicine
2022 .03
-
Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
전남의대학술지
2016 .01
-
Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in NSCLC
Cancer Research and Treatment
2024 .07
-
Development of clinical practice guidelines
대한외과학회 학술대회 초록집
2016 .11
-
순환종양핵산 검사의 임상 적용
Laboratory Medicine Online
2022 .10
최근 본 자료
댓글(0)
0